Overview

Efficacy and Safety Study of Allogenic Mesenchymal Stem Cells for Patients With Refractory Primary Biliary Cirrhosis

Status:
Unknown status

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

The study is designed to evaluate the safety and efficacy of intravenous administration of bone marrow derived mesenchymal stem cells for patients with refractory primary biliary cirrhosis (PBC).

Phase:

Phase 1

Details

Lead Sponsor:

Robert Chunhua Zhao, MD, PhD

Collaborator:

Peking Union Medical College Hospital

Treatments:

Ursodeoxycholic Acid